Picton Mahoney Asset Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28.8M Sell
191,876
-58,115
-23% -$6.32M 0.21% 88
2026
Q1
$23.1M Buy
249,991
+90,962
+57% +$9.13M 0.17% 100
2025
Q4
$16.2M Buy
+159,029
New +$14.2M 0.13% 139
2021
Q4
Sell
-20,190
Closed -$2.53M 979
2021
Q3
$2.53M Sell
20,190
-12,650
-39% -$1.5M 0.09% 261
2021
Q2
$4.08M Buy
32,840
+10,155
+45% +$1.37M 0.12% 139
2021
Q1
$3.46M Buy
+22,685
New +$3.43M 0.17% 174

Other funds holding GH

Picton Mahoney Asset Management's GH Position: Q2 2026 in Review

Picton Mahoney Asset Management reduced its Guardant Health (GH) stake by 23% in Q2 2026, selling an estimated $6.32M and leaving 191,876 shares worth $28.8M. The position accounts for 0.21% of the portfolio, ranked #88.

Picton Mahoney Asset Management first reported a position in GH in Q1 2021 and has held it in 6 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Picton Mahoney Asset Management held 191,876 shares of Guardant Health worth $28.8M as of Q2 2026.
  • Picton Mahoney Asset Management sold 58,115 Guardant Health shares in Q2 2026, an estimated $6.32M.
  • Guardant Health made up 0.21% of Picton Mahoney Asset Management's portfolio in Q2 2026, its #88 holding.
  • Picton Mahoney Asset Management first reported a position in Guardant Health in Q1 2021 and has held it in 6 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Picton Mahoney Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.